(28 days)
KWQ
Not Found
No
The document describes a mechanical spinal fixation system and does not mention any AI or ML components or functionalities.
No
This device is a spinal fixation system, indicated for temporary stabilization during spinal fusions, which points to a structural or supportive role rather than active therapeutic intervention.
No
The device is described as a "cervical spinal fixation device" intended for "temporary stabilization of the anterior spine during the development of cervical spinal fusions." This indicates a therapeutic or supportive function rather than a diagnostic one.
No
The device description explicitly states it is a "cervical spinal fixation device that uses interconnecting links" and mentions "bone anchor screws, the cervical lock nut, and the associated instrumentation," all of which are hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is for "anterior interbody screw fixation of the cervical spine" and "temporary stabilization of the anterior spine during the development of cervical spinal fusions." This describes a surgical implant used directly on the patient's body.
- Device Description: The description details "cervical spinal fixation device that uses interconnecting links" and mentions "bone anchor screws" and "cervical lock nut." These are all components of a surgical implant.
- Lack of IVD Characteristics: There is no mention of the device being used to test samples (like blood, urine, or tissue) in vitro (outside the body) to diagnose a condition. The device is used in vivo (inside the body) for treatment and stabilization.
IVD devices are used to examine specimens from the human body to provide information for diagnosis, monitoring, or screening. This device is a surgical implant used for structural support and stabilization within the body.
N/A
Intended Use / Indications for Use
The EBI SpineLink™ Anterior Cervical Spinal System is intended for anterior interbody screw fixation of the cervical spine at levels C3-C7. The System is indicated for use in the temporary stabilization of the anterior spine during the development of cervical spinal fusions in patients with degenerative disc disease (as defined by neck pain of discogenic origin of the disc confirmed by patient history and radiographic studies), trauma (including fractures), tumors, deformity (defined as kyphosis, lordosis, or scoliosis), pseudarthrosis, and/or failed previous fusions.
Product codes
KWQ
Device Description
The EBI SpineLink™ System is a cervical spinal fixation device that uses interconnecting links. This submission is for design modifications to the previously cleared 4.5mm, 5.5mm, 6.5mm bone anchor screws, the cervical lock nut, and the associated instrumentation.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
cervical spine at levels C3-C7
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
An Engineering Analysis comparing the modifications to the previous system demonstrated that the device complies with applicable standards and meets all of its functional requirements.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
EBI SpineLink™ Anterior Cervical Spinal System, Synthes® Cervical Spine Locking Plate
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3060 Spinal intervertebral body fixation orthosis.
(a)
Identification. A spinal intervertebral body fixation orthosis is a device intended to be implanted made of titanium. It consists of various vertebral plates that are punched into each of a series of vertebral bodies. An eye-type screw is inserted in a hole in the center of each of the plates. A braided cable is threaded through each eye-type screw. The cable is tightened with a tension device and it is fastened or crimped at each eye-type screw. The device is used to apply force to a series of vertebrae to correct “sway back,” scoliosis (lateral curvature of the spine), or other conditions.(b)
Classification. Class II.
0
DEC I O 1899
510(k) Summary of Safety & Effectiveness
This 510(k) Summary of Safety and Effectiveness for the EBI SpineLink™ Anterior Cervical Spinal System is provided as required per Section 513(3) of the Food, Drug and Cosmetic Act.
- Contact Person: Jon Caparotta 1. Submitter: EBI, L.P. Telephone: (973) 299-9022 100 Internace Parkwav Parsippany, NJ 07054
November 9, 1999 Date prepared:
| 2. Proprietary Name: | EBI SpineLink™ Anterior Cervical Spinal System |
|---|---|
| Common Name: | Spinal Fixation Device |
| Classification Names: | Spinal Intervertebral Body Fixation Orthosis |
3. Predicate or legally marketed devices that are substantially equivalent:
- EBI SpineLink™ Anterior Cervical Spinal System �
- Synthes® Cervical Spine Locking Plate �
-
- Description of the device: The EBI SpineLink™ System is a cervical spinal fixation device that uses interconnecting links. This submission is for design modifications to the previously cleared 4.5mm, 5.5mm, 6.5mm bone anchor screws, the cervical lock nut, and the associated instrumentation.
-
- Intended Use: The EBI SpineLink™ Anterior Cervical Spinal System is intended for anterior interbody screw fixation of the cervical spine at levels C3-C7. The System is indicated for use in the temporary stabilization of the anterior spine during the development of cervical spinal fusions in patients with degenerative disc disease (as defined by neck pain of discogenic origin of the disc confirmed by patient history and
1
radiographic studies), trauma (including fractures), tumors, deformity (defined as kyphosis, lordosis, or scoliosis), pseudarthrosis, and/or failed previous fusions.
Warning: This device is not approved for screw attachment to the posterior elements (pedicles) of the cervical, thoracic, or lumbar spine.
-
- Materials: The components of the System are manufactured from Ti-6A1-4V ELI per ASTM F136.
-
- Comparison of the technological characteristics of the device to predicate
devices: There are no significant differences between the EBI SpineLink™ Anterior Cervical Spinal System and other currently marketed spinal systems. It is substantially equivalent* to the predicate devices in regards to intended use, materials, and function. An Engineering Analysis comparing the modifications to the previous system demonstrated that the device complies with applicable standards and meets all of its functional requirements.
- Any statement made in conjunction with this submission regarding a determination of substantial equivalence to any other product is intended only to relate to whether the product can be lawfully marketed without pre-market approval or reclassification and is not interpreted as an admission or any other type of evidence in patent infringement litigation. [Establishment Registration and Premarket Notification Procedures, Final Regulation, Preamble, August 23, 1977, FR 42520 (Docket No. 76N-0355.)]
2
Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized representation of three human profiles facing right, arranged in a stacked formation. The profiles are connected and appear to be flowing or merging into one another. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular fashion around the top half of the logo.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC 1 0 1999
Mr. Jon Caparotta Manager, Regulatory Affairs Electro-Biology, Inc. 100 Interpace Parkway Parsippany, New Jersey 07054
Re: K993822
Trade Name: EBI SpineLink™ Anterior Cervical Spinal System Regulatory Class: II Product Code: KWQ Dated: November 11, 1999 Received: November 12, 1999
Dear Mr. Caparotta:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 - Mr. Jon Caparotta
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597, or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Stypka Schueler
1 James E. Dillard III Acting Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
K993822 Statement of Indications for Use:
The EBI SpineLink™ Anterior Cervical Spinal System is intended for anterior interbody screw fixation of the cervical spine at levels C3-C7. The System is indicated for use in the temporary stabilization of the anterior spine during the development of cervical spinal fusions in patients with degenerative disc disease (as defined by neck pain of discogenic origin of the disc confirmed by patient history and radiographic studies), trauma (including fractures), tumors, deformity (defined as kyphosis, lordosis, or scoliosis), pseudarthrosis, and/or failed previous fusions.
Warning: This device is not approved for screw attachment to the posterior elements (pedicles) of the cervical, thoracic, or lumbar spine.
Hupt Purdy
vision of General Restorative Deyices 510(k) Number .
Over-the-Counter Use _________________________________________________________________________________________________________________________________________________________
Prescription Use (Per 21 CFR 801.109)